Drug intelligence / Profile preview

Guilu Erxian Oral Liquid

Development stage
Phase 4
Lead developer
Dong-E-E-Jiao
Administration
Oral
01

Overview

Guilu Erxian Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed by Shandong Dong'e Ejiao Co., Ltd. It is primarily indicated for the treatment of conditions associated with Kidney Yang and Essence deficiency, including spermatorrhea, impotence, oligozoospermia, and asthenospermia. The formulation is a liquid version of the classic Guilu Erxian decoction, which typically contains four key ingredients: Deer Antler (Lujiao), Tortoise Plastron (Guiban), Ginseng (Ren-shen), and Wolfberry (Gou-qi-zi). Its therapeutic mechanism involves warming the kidney, replenishing essence, and nourishing blood to improve reproductive health and physical vitality. Clinical trials have focused on its efficacy and safety in improving sperm parameters and treating male infertility symptoms associated with Kidney Essence deficiency.

Brand names
Guilu Erxian Oral Liquid
Other names
Guilu Erxian JiaoGuilu Erxian WanGuilu Erxian Tang
02

Targets

SIRT1 (NAD-dependent protein deacetylase sirtuin-1)

Beyond the preview

Go deeper on Guilu Erxian Oral Liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guilu Erxian Oral Liquid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call